Skip to main content

Table 2 Logistic regression analysis of predictor for csPC

From: A comparative study of transperineal software-assisted magnetic resonance/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate

  Univariate Multivariate
OR 95% CI p OR 95% CI p
Age 1.06 1.02–1.1 0.003 1.05 1.01–1.1 0.023
Prior negative biopsy 0.62 0.32–1.19 0.149    
DRE       
 Negative reference      
 Positive 0.58 0.31–1.09 0.089    
PSA 1.04 1.00–1.08 0.055 1.03 0.99–1.06 0.111
PI-RADS       
 3 reference      
 > 3 5.25 1.72–16.02 0.004 5.99 1.72–20.84 0.005
Number of total cores 1.03 0.98–1.09 0.276    
Biopsy route       
 Transperineal 1.99 1.09–3.63 0.026 2.55 1.32–4.95 0.006
 Transrectal Reference      
Target lesion location       
 Posterior Reference      
 Anterior 2.02 1.09–3.74 0.026 1.81 0.91–3.57 0.09
  1. CI: confidence interval; csPC: clinically significant prostate cancer; DRE: digital rectal exam; OR: odds ratio; PSA: prostate specific antigen; PI-RADS: Prostate Imaging Reporting & Data System